CLEARONE INC (CLRO) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | (m) | |
| Stock-based compensation | 35.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -4.15M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $35.00K | $-4.15M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $56.00K | $-4.42M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $79.00K | $-4.40M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.30M | (m) | $91.00K | $-9.97M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.59M | (m) | $90.00K | $-11.61M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $3.10M | (m) | $95.00K | $-9.98M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $3.30M | (m) | $98.00K | $-9.21M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $3.41M | (m) | $102.00K | $-8.93M | $-196.00K | (m) | (m) | (m) | Reported |
| 2024-06-30 | $3.52M | (m) | $114.00K | $-8.23M | $154.00K | (m) | (m) | -53.44× | Reported |
| 2024-03-31 | $3.52M | (m) | $112.00K | $-6.66M | $245.00K | (m) | (m) | -27.19× | Reported |
| 2023-12-31 | $3.67M | (m) | $109.00K | $-6.77M | $537.00K | (m) | (m) | -12.61× | Reported |
| 2023-09-30 | $3.79M | (m) | $103.00K | $-7.62M | $604.00K | (m) | (m) | -12.62× | Reported |
| 2023-06-30 | $3.78M | (m) | $95.00K | $-7.26M | $608.00K | (m) | (m) | -11.95× | Reported |
| 2023-03-31 | $4.08M | (m) | $100.00K | $-7.56M | $611.00K | (m) | (m) | -12.37× | Reported |
| 2022-12-31 | $4.39M | (m) | $113.00K | $-7.22M | $420.00K | (m) | (m) | -17.20× | Reported |
| 2022-09-30 | $4.95M | (m) | $126.00K | $-7.11M | $430.00K | (m) | (m) | -16.53× | Reported |
| 2022-06-30 | $5.56M | (m) | $136.00K | $-7.99M | $490.00K | (m) | (m) | -16.30× | Reported |
| 2022-03-31 | $5.87M | (m) | $141.00K | $-7.82M | $503.00K | (m) | (m) | -15.55× | Reported |
| 2021-12-31 | $5.79M | (m) | $136.00K | $-7.50M | $514.00K | (m) | (m) | -14.58× | Reported |
| 2021-09-30 | $5.45M | (m) | $108.00K | $-5.84M | $480.00K | (m) | (m) | -12.16× | Reported |
| 2021-06-30 | $5.46M | (m) | $74.00K | $-4.99M | $438.00K | (m) | (m) | -11.39× | Reported |
| 2021-03-31 | $5.44M | (m) | $57.00K | $-5.34M | $440.00K | (m) | (m) | -12.14× | Reported |
| 2020-12-31 | $5.51M | (m) | $63.00K | $-5.57M | $436.00K | (m) | (m) | -12.77× | Reported |
| 2020-09-30 | $5.77M | (m) | $95.00K | $-6.72M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $5.70M | (m) | $142.00K | $-7.66M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $5.53M | (m) | $180.00K | $-7.92M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $5.78M | (m) | $217.00K | $-8.56M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $6.41M | (m) | $261.00K | $-9.20M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $6.76M | (m) | $326.00K | $-9.41M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $7.37M | (m) | $400.00K | $-10.28M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $7.84M | (m) | $463.00K | $-10.33M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $8.15M | (m) | $530.00K | $-8.78M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $8.64M | (m) | $591.00K | $-19.97M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $9.04M | (m) | $631.00K | $-18.11M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $9.34M | $41.80M | $665.00K | $-16.19M | (m) | 22.35% | 1.59% | (m) | (m) |
| 2017-09-30 | $9.05M | $43.28M | $687.00K | $-16.29M | (m) | 20.91% | 1.59% | (m) | (m) |
| 2017-06-30 | $8.90M | $45.63M | $688.00K | $-1.36M | (m) | 19.50% | 1.51% | (m) | (m) |
| 2017-03-31 | $8.67M | $47.28M | $690.00K | $1.07M | (m) | 18.34% | 1.46% | (m) | (m) |
| 2016-12-31 | $8.58M | $48.64M | $667.00K | $3.57M | (m) | 17.65% | 1.37% | (m) | (m) |
| 2016-09-30 | $8.67M | $52.19M | (m) | $7.28M | (m) | 16.61% | (m) | (m) | (m) |
| 2016-06-30 | $8.69M | $55.20M | (m) | $9.36M | (m) | 15.74% | (m) | (m) | (m) |
| 2016-03-31 | $8.65M | $57.24M | (m) | $10.34M | (m) | 15.11% | (m) | (m) | (m) |
| 2015-12-31 | $8.32M | $57.80M | (m) | $10.26M | (m) | 14.39% | (m) | (m) | (m) |
| 2015-09-30 | $8.21M | $58.86M | (m) | $10.91M | (m) | 13.95% | (m) | (m) | (m) |
| 2015-06-30 | $8.39M | $58.69M | (m) | $10.37M | (m) | 14.30% | (m) | (m) | (m) |
| 2015-03-31 | $8.67M | $58.79M | (m) | $9.12M | (m) | 14.75% | (m) | (m) | (m) |
| 2014-12-31 | $8.97M | $57.91M | (m) | $7.97M | (m) | 15.49% | (m) | (m) | (m) |
| 2014-09-30 | $8.95M | $56.79M | (m) | $7.69M | (m) | 15.76% | (m) | (m) | (m) |
| 2014-06-30 | $8.42M | $53.41M | (m) | $6.95M | (m) | 15.77% | (m) | (m) | (m) |
| 2014-03-31 | $7.94M | $51.01M | (m) | $7.31M | (m) | 15.56% | (m) | (m) | (m) |
| 2013-12-31 | $7.56M | $49.59M | (m) | $7.62M | (m) | 15.25% | (m) | (m) | (m) |
| 2013-09-30 | $7.76M | $48.40M | (m) | $43.99M | (m) | 16.04% | (m) | (m) | (m) |
| 2013-06-30 | $7.93M | $47.60M | (m) | $43.15M | (m) | 16.66% | (m) | (m) | (m) |
| 2013-03-31 | $8.12M | $47.56M | (m) | $42.85M | (m) | 17.07% | (m) | (m) | (m) |
| 2012-12-31 | $8.26M | $46.42M | (m) | $42.52M | (m) | 17.80% | (m) | (m) | (m) |
| 2012-09-30 | $-6.38M | $45.35M | (m) | $5.35M | (m) | -14.07% | (m) | (m) | (m) |
| 2012-06-30 | $-7.71M | $45.28M | (m) | $9.32M | (m) | -17.03% | (m) | (m) | (m) |
| 2012-03-31 | $-7.50M | $45.52M | (m) | $10.07M | (m) | -16.47% | (m) | (m) | (m) |
| 2011-12-31 | $7.13M | $46.07M | (m) | $10.57M | (m) | 15.47% | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $7.74M | $41.28M | (m) | $1.80M | (m) | 18.75% | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DNA X, Inc. (SONM) | United States | $0.006B | -0.90 |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |